Targeted Therapy of Advanced Gallbladder Cancer and Cholangiocarcinoma with Aggressive Biology: Eliciting Early Response Signals from Phase 1 trials

類似資料

• Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials
  著者:: Subbiah, Ishwaria M., 等
  出版事項: (2015)
• Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer
  著者:: Falchook, Gerald S., 等
  出版事項: (2014)
• Xilonix, a Novel True Human Antibody Targeting the Inflammatory Cytokine Interleukin-1 alpha, in Non-Small Cell Lung Cancer
  著者:: Hong, David S., 等
  出版事項: (2015)
• P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy
  著者:: Said, Rabih, 等
  出版事項: (2013)
• Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population
  著者:: Wheler, Jennifer, 等
  出版事項: (2013)